1. Directory
  2. Oregon
  3. Beaverton
  4. Subcutaneous Drug Development and Delivery Consortium
EIN 85-0837695

Subcutaneous Drug Development and Delivery Consortium

IRS 501(c) type
501(c)(6)
Num. employees
0
City
Beaverton
State
Oregon
Year formed
2020
Most recent tax filings
2022-12-01
NTEE code, primary
S40: Business and Industry
Description
Subcutaneous Drug Development and Delivery Consortium collaboratively advances pressing issues and opportunities in subcutaneous dosage and delivery in a precompetitive manner. It developed the sc Consortium's 5-year strategic plan, which maps critical steps necessary to achieve its mission and vision, as well as sub-team roadmaps to detail the desired future state and key supporting activities to engage.
Total revenues
$406,250
2022
Total expenses
$537,991
2022
Total assets
$685,644
2022
Num. employees
0
2022

Program areas at Subcutaneous Drug Development and Delivery Consortium

Bioavailability collaborative research project: 'Development of in vitro, preclinical and in silico models to predict the human Subcutaneous absorption and overall bioavailability of mabs'.
Annual pegs boston conference and expo user group. 'sc administration and immunogenicity risk; current understanding and future considerations for novel modalities'.
American association of pharmaceutical scientists (aaps) workshop 'roadmapping the clinical and regulatory paths of Subcutaneous products and technologies'.

Personnel at Subcutaneous Drug Development and Delivery Consortium

NameTitleCompensation
Donna FrenchPresident$0
Sachin MittalVice President$0
David KangTreasurer$0
David CollinsPresident$0

Financials for Subcutaneous Drug Development and Delivery Consortium

RevenuesFYE 12/2022
Total grants, contributions, etc.$0
Program services$406,250
Investment income and dividends$0
Tax-exempt bond proceeds$0
Royalty revenue$0
Net rental income$0
Net gain from sale of non-inventory assets$0
Net income from fundraising events$0
Net income from gaming activities$0
Net income from sales of inventory$0
Miscellaneous revenues$0
Total revenues$406,250

Form 990s for Subcutaneous Drug Development and Delivery Consortium

Fiscal year endingDate received by IRSFormPDF link
2022-122023-10-24990View PDF
2021-122022-09-01990View PDF
2020-122022-08-22990OView PDF
2020-122022-08-10990View PDF
Data update history
November 27, 2023
Posted financials
Added Form 990 for fiscal year 2022
November 27, 2023
Updated personnel
Identified 1 new personnel
August 14, 2023
Posted financials
Added Form 990 for fiscal year 2021
May 14, 2023
Updated personnel
Identified 15 new personnel
May 9, 2023
Posted financials
Added Form 990 for fiscal year 2020
Nonprofit Types
Business and community development organizationsResearch centers
Issues
Science and technologyPublic policyBusiness and industry
Characteristics
MembershipsConducts researchState / local levelNo full-time employees
General information
Address
3855 SW 153rd Dr
Beaverton, OR 97003
Metro area
Portland-Vancouver-Hillsboro, OR-WA
County
Washington County, OR
Website URL
subcutaneousconsortium.org/ 
Phone
(503) 619-0505
IRS details
EIN
85-0837695
Fiscal year end
December
Taxreturn type
Form 990
Year formed
2020
Eligible to receive tax-deductible contributions (Pub 78)
No
Categorization
NTEE code, primary
S40: Business and Industry
NAICS code, primary
5417: Scientific Research and Development Services
Parent/child status
Independent
Free account sign-up

Want updates when Subcutaneous Drug Development and Delivery Consortium has new information, or want to find more organizations like Subcutaneous Drug Development and Delivery Consortium?

Create free Cause IQ account
Cause IQ is a website that helps companies grow, maintain, and serve their nonprofit clients, and helps nonprofits find additional foundation funding. Our data and tools help professionals prospect for nonprofits, research opportunities, benchmark their clients, and enrich existing information.
Nonprofits
Product
Customers
About

© 2024 Nonprofit Metrics LLC
Terms of Service and Privacy Policy